Inhibition of drug binding to human serum albumin by cholecystographic agents.
Carlo Bertucci, Samanta Cimitan
Index: Il Farmaco 58(9) , 901-8, (2003)
Full Text: HTML
Abstract
The binding of two cholecystographic agents to human serum albumin (HSA) was evaluated by means of two different complementary methodologies. In particular, the inhibition of drug HSA binding caused by iopanoic- and iophenoxic-acid was investigated by circular dichroism (CD) and resonant mirror (RM) optical biosensor techniques. The CD study allowed to obtain information both on the cholecystographic agent binding site and on the effect of the binding on the protein conformation. Iopanoic acid (IOP), a drug potentially useful for thyrotoxic disorders, resulted a direct competitor for ligands that selectively bind to site II, in agreement to literature data. No definite evidence was obtained for the highest affinity binding site of iophenoxic acid (IOPH), however, this diagnostic tool markedly affected the binding of ligands to the most characterized high affinity sites on HSA, namely sites I, II and III. Binding parameters were obtained by optical biosensor analysis: K(D) values were 3.6 x 10(-7) and 2.8 x 10(-8) M for IOP and IOPH, respectively.
Related Compounds
Related Articles:
Selective analysis of human serum albumin based on SEC-ICP-MS after labelling with iophenoxic acid.
2015-04-01
[Anal. Bioanal. Chem 407(10) , 2829-36, (2015)]
2011-01-01
[BMC Struct. Biol. 11 , 18, (2011)]
2006-02-17
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 832(1) , 144-57, (2006)]
1988-08-01
[Mol. Pharmacol. 34(2) , 160-71, (1988)]
[Recent triiodinated contrast media for oral cholecystocholangiography].
1985-02-01
[Med. Radiol. (Mosk.) 30(2) , 58-60, (1985)]